Limor Rubin

BRAF<sup><b>V600E</b></sup> Metastatic Synovial Sarcoma Treated with BRAF & MEK Inhibitors Achieves Complete Response. A Case Report & Literature Review

Clinical significance of very high IgE levels (≥1000 IU/mL): Population-based study of 118,211 adults

<scp>IgE</scp> deficiency (&lt;2.5 <scp>IU</scp> / <scp>mL</scp> ) in children: Clinical insights from a population‐based study of 123,393 subjects

Dual biological treatments in immune-mediated disorders: a single center experience

Preclinical evidence using synthetic compounds and natural products indicates that AMPK represents a potential pharmacological target for the therapy of pulmonary diseases

Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse events

Rasagiline Exerts Neuroprotection towards Oxygen–Glucose-Deprivation/Reoxygenation-Induced GAPDH-Mediated Cell Death by Activating Akt/Nrf2 Signaling

Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome

Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for Anaphylaxis

Increased rates of idiopathic inflammatory myopathies during the COVID-19 pandemic: a single-centre experience

Dupilumab for cancer-associated refractory pruritus

Food‐induced anaphylaxis during infancy is associated with later sleeping and eating disorders

Successful ligelizumab treatment of severe refractory solar urticaria

A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinations

Food allergy is associated with increased risk of developing psychological disorders: A nationwide study of 603,257 Israelis

Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity

Current Progress on Neuroprotection Induced by Artemisia, Ginseng, Astragalus, and Ginkgo Traditional Chinese Medicines for the Therapy of Alzheimer’s Disease

Pharmacological therapies and drug development targeting SARS-CoV-2 infection

Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience

B cell-derived cfDNA after primary BNT162b2 mRNA vaccination anticipates memory B cells and SARS-CoV-2 neutralizing antibodies

Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity‐induced rash in patients with multiple myeloma

Melanocyte-secreted fibromodulin constrains skin inflammation in mice injected with lupus serum

Autoimmune Diseases Induced or Exacerbated by COVID-19: A Single Center Experience

Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy

Autoimmune phenomena following SARS-CoV-2 vaccination

Neurotrophic factors and their receptors in lung development and implications in lung diseases

Predictors of Hypoxemia and Related Adverse Outcomes in Patients Hospitalized with COVID-19: A Double-Center Retrospective Study

Synthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of α4β1 (VLA-4)/α9β1 Integrin for Therapy of Multiple Sclerosis